Clinical Trial Update: Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial reports the single-dose pharmacokinetics of repaglinide, metformin, and the combination tablet in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)
• Prandin (repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED